Alignment Healthcare, Inc. $ALHC Stake Lifted by Next Century Growth Investors LLC

Next Century Growth Investors LLC increased its holdings in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 1.6% in the fourth quarter, Holdings Channel reports. The firm owned 2,308,287 shares of the company’s stock after acquiring an additional 35,542 shares during the period. Alignment Healthcare accounts for 3.2% of Next Century Growth Investors LLC’s investment portfolio, making the stock its 5th biggest position. Next Century Growth Investors LLC’s holdings in Alignment Healthcare were worth $45,589,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Parallel Advisors LLC increased its position in Alignment Healthcare by 87.7% during the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock worth $33,000 after purchasing an additional 773 shares in the last quarter. Larson Financial Group LLC acquired a new stake in Alignment Healthcare during the 3rd quarter worth approximately $33,000. First Horizon Corp acquired a new stake in Alignment Healthcare during the 4th quarter worth approximately $39,000. GAMMA Investing LLC increased its position in Alignment Healthcare by 83.8% during the 4th quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock worth $43,000 after purchasing an additional 987 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB acquired a new stake in Alignment Healthcare during the 3rd quarter worth approximately $53,000. Institutional investors and hedge funds own 86.19% of the company’s stock.

Insider Buying and Selling at Alignment Healthcare

In related news, insider Mark D. Kent purchased 14,848 shares of the firm’s stock in a transaction dated Tuesday, June 2nd. The stock was acquired at an average price of $13.31 per share, with a total value of $197,626.88. Following the completion of the transaction, the insider owned 14,848 shares of the company’s stock, valued at $197,626.88. This represents a ? increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO John E. Kao sold 298,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 10th. The stock was sold at an average price of $20.36, for a total transaction of $6,067,280.00. Following the sale, the chief executive officer directly owned 1,386,766 shares of the company’s stock, valued at $28,234,555.76. The trade was a 17.69% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 1,584,685 shares of company stock valued at $30,401,143. Corporate insiders own 5.20% of the company’s stock.

Alignment Healthcare Stock Down 2.4%

Shares of NASDAQ:ALHC opened at $19.75 on Friday. The company has a quick ratio of 1.58, a current ratio of 1.58 and a debt-to-equity ratio of 1.56. Alignment Healthcare, Inc. has a 52-week low of $11.63 and a 52-week high of $23.87. The company has a 50 day moving average of $18.53 and a two-hundred day moving average of $19.40. The company has a market capitalization of $4.08 billion, a price-to-earnings ratio of 219.44, a price-to-earnings-growth ratio of 2.67 and a beta of 1.14.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings data on Thursday, April 30th. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.04. Alignment Healthcare had a net margin of 0.47% and a return on equity of 11.50%. The company had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.22 billion. During the same quarter last year, the company earned ($0.05) earnings per share. Alignment Healthcare’s revenue for the quarter was up 33.3% on a year-over-year basis. As a group, analysts forecast that Alignment Healthcare, Inc. will post 0.2 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts recently issued reports on ALHC shares. UBS Group increased their target price on shares of Alignment Healthcare from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Friday, May 1st. Weiss Ratings raised shares of Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Thursday, May 7th. Barclays dropped their target price on shares of Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 26th. Wall Street Zen raised shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Finally, Raymond James Financial set a $22.00 target price on shares of Alignment Healthcare in a research report on Thursday, May 7th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $24.30.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.